C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
11/2002
11/28/2002	WO2002094799A2 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
11/28/2002	WO2002094787A1 2-oxo-piperidinyl- and 2-oxo-azepanyl alkanoic acid derivativ es for the treatment of epilepsy and other neurological disorders
11/28/2002	WO2002094786A1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain anxiety or gastrointestinal disorders
11/28/2002	WO2002094785A1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002	WO2002094784A1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002	WO2002094783A1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002	WO2002094782A1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derativatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002	WO2002094781A1 Method for the production of biperiden ii
11/28/2002	WO2002094770A2 Aminoalcohol derivatives
11/28/2002	WO2002078641A3 Pyrrolidine sulfonamides
11/28/2002	WO2001092219A1 Glycinamides
11/28/2002	WO2001092214A1 Carbamic acid esters as inhibitors of factor xa
11/28/2002	US20020177721 Analgesics
11/28/2002	US20020177608 Polymorphs of fexofenadine hydrochloride
11/28/2002	US20020177607 Ligands for receptors such as dopamine, serotonin, or norepinephrine transporters; broad uses claimed, such as pain reliever and antidepressant
11/28/2002	US20020177593 Non-carbamate amine acetylcholinesterase inhibitor and a carrier; for example, 9-amino-1,2,3,4-tetrahydroacridine or 8-(3-(1-((3-fluorophenyl)methyl)-4-piperidinyl)-1-oxopropyl)-1,2,5,6 -tetrahydro-4H-pyrrolo(3,2,1-ij)quinolin-4-one
11/28/2002	US20020177588 Selectivity
11/28/2002	CA2448080A1 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
11/28/2002	CA2448076A1 3-quinoline-2-(1h)-ylideneindolin-2-one derivatives
11/28/2002	CA2446516A1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002	CA2446332A1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002	CA2446331A1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002	CA2446316A1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002	CA2446313A1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002	CA2446311A1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derativatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002	CA2446155A1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain anxiety or gastrointestinal disorders
11/28/2002	CA2446154A1 4-(penyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002	CA2410628A1 Carbamic acid esters
11/28/2002	CA2410627A1 Glycinamides
11/27/2002	EP1260505A1 A process for the preparation of 4-[1-hydroxy-4-(4-(hydroxydiphenylmethyl)-1-piperidinyl)-butyl]-alpha, alpha-dimethylbenzeneacetic acid
11/27/2002	EP1260504A1 Process for the preparation of antihistaminic 4-diphenylmethyl piperidine derivatives
11/27/2002	EP1260232A1 Remedies for malignant tumor-concomitant neurosis and azoor or analogous diseases thereof
11/27/2002	EP1259484A1 Carboxamides useful as inhibitors of microsomal triglyceride transfer protein and of apolipoprotein b secretion
11/27/2002	EP1114024B1 Urokinase inhibitors
11/27/2002	EP1000048B1 Substituted 1,2,3,4-tetrahydronaphthalene derivatives
11/27/2002	EP0844825B1 Insecticidal n-(substituted arylmethyl)-4- bis(substituted phenyl or pyridyl)methyl]piperidines
11/27/2002	EP0777492A4 Combinatorial libraries of substrate-bound cyclic organic compounds
11/27/2002	CN1382140A Neurotrophic pyrrolidines and piperidines and related compositions containing them
11/27/2002	CN1382135A Amine and amide derivatives as ligands for neuropeptide YY5 receptor usefu in treatment of obesity and other disorders
11/27/2002	CN1094926C Antimer pure acetacetates, its preparation method and use
11/26/2002	US6486325 Process for the preparation of piperidinylaminomethyl trifluoromethyl cyclic ether compounds
11/26/2002	US6486238 Hindered amine compound, resin composition, polyurethane fiber and production method and use thereof
11/26/2002	US6486180 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
11/26/2002	US6486177 Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate
11/26/2002	CA2231364C Novel n-aminoalkylfluorenecarboxamides; a new class of dopamine receptor subtype specific ligands
11/26/2002	CA2051855C Process for producing n-substituted-1-deoxynojirimycin
11/21/2002	WO2002092592A1 Novel 1-amidomethylcarbonyl-piperidine derivatives, method and intermediate products for the production thereof and medicament containing said compounds
11/21/2002	WO2002092588A2 Aromatic sulfone hydroxamates and their use as protease inhibitors
11/21/2002	WO2002068416A3 Process of preparing paroxetine and intermediates for use therein
11/21/2002	WO2002042271A3 Biphenylcarboxamides useful as lipid lowering agents
11/21/2002	US20020173656 Guanidine and amidine derivatives as factor Xa inhibitors
11/21/2002	US20020173646 Quinazoline derivatives and pharmaceutical compositions containing them
11/21/2002	US20020173536 Enantiomerically pure basic arylcycloalkylhydroxycarboxylic esters, processes for their preparation and their use in medicaments
11/21/2002	US20020173508 Enzyme inhibitors; antiinflammatory agents, antiarthritic agents
11/21/2002	US20020173494 Ammonium salts of inositol hexaphosphate, and uses thereof
11/21/2002	DE10124449A1 Preparation of biperiden used for treating Parkinson's disease by reacting phenylmagnesium compound and bicycloheptenenyl substituted propanone of high exo/endo ratio
11/21/2002	CA2446586A1 Aromatic sulfone hydroxamates and their use as protease inhibitors
11/20/2002	EP1258477A1 Resolution of the enantiomers of amlodipine
11/20/2002	EP1258250A1 Nerve protective drugs
11/20/2002	EP1258244A1 High affinity ligands for nociceptin receptor ORL-1
11/20/2002	EP1257544A2 Piperazine and piperidine derivatives for treatment or prevention of neuronal damage
11/20/2002	EP1257541A2 Polypharmacophoric agents
11/20/2002	EP0929530B1 Quinazoline derivatives and pharmaceutical compositions containing them
11/20/2002	EP0917465B1 Antimalarial and anti-babesiosis agents and pharmaceutical compositions containing the same agents
11/20/2002	CN1094486C Benzal compound and preparation method
11/19/2002	US6482840 Substituted cyclic amidine derivatives as inhibitors of cell adhesion
11/19/2002	US6482838 Cholinesterase inhibitor
11/19/2002	CA2244021C Quaternary substituted bleach activators
11/17/2002	CA2386452A1 A process for the preparation of 4-[1-hydroxy-4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-butyl]-alpha,alpha-dimethylbenzeacetic acid
11/14/2002	WO2002090351A1 Process for producing carbostyril derivative
11/14/2002	WO2002090314A1 Pyruvate derivatives
11/14/2002	WO2002089803A1 Composition for iontophoresis
11/14/2002	WO2002089800A2 N-aroyl cyclic amine derivatives as orexin receptor antagonists
11/14/2002	WO2002072577A3 Azacycloalkyl substituted acetic acid derivatives for use as mmp inhibitors.
11/14/2002	WO2002064550A8 Glucocorticoid receptor modulators
11/14/2002	WO2002062324A3 A treatment of oesophageal motility disorders and gastro-oesophageal reflux disease
11/14/2002	US20020169324 N-substituted(+)-(3R,4R)-dimethyl-4-(3-hydroxyphenyl)piperidine compounds; opiod receptors
11/14/2002	US20020169323 Selective serotonin reuptake inhibitor; antidepressant, anti-Parkinson agent
11/14/2002	US20020169157 An aromatic or heteroaromatic amino acid derivative, used for treating disorders related to overexpression of protein tyrosine phosphatase-1B
11/14/2002	US20020169155 A nitrogen-ring containing triheterocyclic compound is useful for treating a disease associated with aberrant leukocyte recruitment and/or activation
11/14/2002	US20020169153 Substituted aromatic compounds for treatment of antibiotic resistant infections
11/14/2002	US20020169098 Cleaning composition
11/14/2002	DE10122603A1 New 1-amidocarbonylmethyl-piperidine derivatives, useful for treating gastrointestinal motility disorders and gastro-esophageal reflux, are motilin agonists
11/13/2002	EP1256576A1 Fused imidazolium derivatives
11/13/2002	EP1256575A1 Phenoxyalkylamine derivatives useful as opioid delta receptor agonists
11/13/2002	EP1255748A1 Beta-alanine derivatives and their use as receptor antagonists
11/13/2002	EP1255524A1 Dental composition with light stability
11/13/2002	EP1102762B1 2-substituted-1-piperidyl benzimidazole compounds as orl1-receptor agonists
11/13/2002	EP0912515B1 1,4-di-substituted piperidines as muscarinic antagonists
11/13/2002	EP0699074B1 Thrombin inhibitors
11/12/2002	US6479663 Intermediates useful for the preparation of antihistaminic piperidine derivatives
11/12/2002	US6479662 Antitumor dibenzofluorene derivatives
11/12/2002	US6479554 Immunotherapeutic agents
11/12/2002	US6479524 To prolong the thrombin time
11/12/2002	US6479519 Inhibitors of cell adhesion; treatment of asthma or inflammatory bowel disease
11/12/2002	US6479518 Zwitterionic tachykinin receptor antagonists
11/12/2002	US6479516 4-arylpiperidine derivatives for the treatment of pruritus
11/12/2002	US6479502 Hydroxamic acid derivatives as proteinase inhibitors
11/12/2002	US6479492 Compounds which inhibit leukocyte adhesion mediated by VLA-4
11/12/2002	US6479484 Substituted 2-aminoacetamides and the discovery that these compounds act as blockers of sodium channels; pain relievers, treatment of arrythmia, local anesthetics

1 ... 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 ... 380